Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Ophthalmology
|
November 18, 2025
Iridescent Particle in Phacolytic Glaucoma
Zige Fang, Xiulan Zhang
BMC Ophthalmology
|
April 4, 2025
Phacoemulsification combined with trabecular meshwork-Schlemm canal-based minimally invasive glaucoma surgery in primary angle-closure glaucoma: a systematic review and meta-analysis
Zige Fang, Yunhe Song, Ling Jin, et al.
Surgery Today
|
November 8, 2022
Effects of preoperative needle biopsy for lung cancer on survival and recurrence: a systematic review and meta-analysis
Meiqi Hao, Zige Fang, Jiatong Ding, et al.
Frontiers in Medicine
|
August 18, 2022
Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
Nachuan Luo, Xun Jiang, Meiqi Hao, et al.
Journal of Clinical Pharmacy and Therapeutics
|
September 20, 2021
Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta-analysis based on randomized controlled trials
Qian Wu, Miaowen Liu, Zige Fang, et al.
Journal of Clinical Pharmacy and Therapeutics
|
October 7, 2021
The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non-small cell lung cancer: A meta-analysis of randomized controlled trials
Miaowen Liu, Nachuan Luo, Zige Fang, et al.
Journal of Clinical Pharmacy and Therapeutics
|
June 8, 2021
The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non-small cell lung cancer: A systematic analysis and meta-analysis based on randomized controlled trials
Qiangyun Liu, Zige Fang, Miaowen Liu, et al.
Cancer Chemotherapy and Pharmacology
|
February 1, 2023
PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials
Chenxi Li, Meiqi Hao, Zige Fang, et al.
Chemotherapy
|
September 13, 2021
Topotecan plus Platinum-Based Chemotherapy versus Etoposide plus Platinum-Based Chemotherapy for Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mengyu He, Bingxuan Wu, Qiangyun Liu, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
March 16, 2026
Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma: Two-year Results of a Prospective Multicenter Study
Fengbin Lin, Yuhong Wang, Xuanchu Duan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Ophthalmology
|
November 18, 2025
Iridescent Particle in Phacolytic Glaucoma
Zige Fang, Xiulan Zhang
BMC Ophthalmology
|
April 4, 2025
Phacoemulsification combined with trabecular meshwork-Schlemm canal-based minimally invasive glaucoma surgery in primary angle-closure glaucoma: a systematic review and meta-analysis
Zige Fang, Yunhe Song, Ling Jin, et al.
Surgery Today
|
November 8, 2022
Effects of preoperative needle biopsy for lung cancer on survival and recurrence: a systematic review and meta-analysis
Meiqi Hao, Zige Fang, Jiatong Ding, et al.
Frontiers in Medicine
|
August 18, 2022
Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
Nachuan Luo, Xun Jiang, Meiqi Hao, et al.
Journal of Clinical Pharmacy and Therapeutics
|
September 20, 2021
Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta-analysis based on randomized controlled trials
Qian Wu, Miaowen Liu, Zige Fang, et al.
Journal of Clinical Pharmacy and Therapeutics
|
October 7, 2021
The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non-small cell lung cancer: A meta-analysis of randomized controlled trials
Miaowen Liu, Nachuan Luo, Zige Fang, et al.
Journal of Clinical Pharmacy and Therapeutics
|
June 8, 2021
The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non-small cell lung cancer: A systematic analysis and meta-analysis based on randomized controlled trials
Qiangyun Liu, Zige Fang, Miaowen Liu, et al.
Cancer Chemotherapy and Pharmacology
|
February 1, 2023
PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials
Chenxi Li, Meiqi Hao, Zige Fang, et al.
Chemotherapy
|
September 13, 2021
Topotecan plus Platinum-Based Chemotherapy versus Etoposide plus Platinum-Based Chemotherapy for Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mengyu He, Bingxuan Wu, Qiangyun Liu, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
March 16, 2026
Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma: Two-year Results of a Prospective Multicenter Study
Fengbin Lin, Yuhong Wang, Xuanchu Duan, et al.
Page
of 2